The state’s grossly unfair drugs policy is enough to make you sick
The government response to the CervicalCheck debacle means patients can only access the latest drugs if they have the ‘right’ illness
Picture this. You have endometrial cancer. The latest clinical trials show that a new drug called Keytruda, or Pembrolizumab, is generating some great results.
About 40 per cent of patients like you - with endometrial cancer - respond to ‘Pembro’ according to the latest trials, but the health service won’t fund it.
The health service is funding that drug for patients with cervical cancer, even though only 12 per cent of those patients respond.
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply